Related Experiment Video
Updated: Jun 25, 2026

07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Visualizing anti-tumor immune responses in vivo
Disease Models & Mechanisms
|March 5, 2009
Summary
Real-time imaging of tumor microenvironment cells offers new insights into cancer progression and treatment response. Understanding stromal and immune cells is crucial for developing effective cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Biomedical Imaging
Background:
- The tumor microenvironment (TME) comprises stromal and immune cells crucial for tumor growth and metastasis.
- Current methods for studying the TME are often static or lack resolution.
- Real-time imaging techniques are emerging to visualize dynamic cellular interactions within the TME.
Discussion:
- Real-time imaging allows for dynamic observation of stromal and immune cell behaviors in vivo.
- This approach can reveal how these non-malignant cells influence tumor progression and therapeutic outcomes.
- Understanding these interactions is key to developing targeted cancer therapies.
Key Insights:
- Emerging real-time imaging modalities provide unprecedented views of cellular dynamics in tumors.
- Visualizing stromal and immune cell roles in real-time enhances our comprehension of tumor biology.
- This field holds significant potential for identifying novel therapeutic targets.
Outlook:
- Further development of real-time imaging technologies will accelerate discoveries in cancer research.
- Translational applications include improved diagnostics and personalized treatment strategies.
- Harnessing insights from dynamic TME imaging could revolutionize cancer therapy.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019